BREAKING
Home » Archive by Category "Drugs and antibiotics" (Page 4)
Image/harshahars

River blindness drug, Moxidectin, receives FDA approval

By

Medicines Development for Global Health (MDGH) and the World Health Organisation Special Programme for Research and Training in Tropical Diseases (TDR) announced today that the United States (U.S.)...

Image/CDC

Shigella infections treated with ciprofloxacin or azithromycin: CDC recommendations updated

By

In a follow-up to recommendations published in April 2017, the Centers for Disease Control and Prevention (CDC) issued updated recommendations on management and reporting of Shigella infections that...

Image/Robert Herriman

Multi-drug-resistant (MDR), colistin-resistant E. coli bacteria pervasive in Vietnam village

By

A new study has found that the majority of residents in a rural village of Vietnam harbored multi-drug-resistant (MDR), colistin-resistant E. coli bacteria. Colistin is typically used as a last-resort...

Image/PublicDomainPictures via pixabay

Crimean Congo hemorrhagic fever: Is ribavirin an effective treatment? Researchers say they don’t know

By

In a viral haemorrhagic disease where up to 40% of people developing it die, it is remarkable that doctors still do not agree whether the only recognized treatment, an antiviral drug called ribavirin,...

Image/harshahars

PKU treatment, Palynziq, receives FDA approval

By

The U.S. Food and Drug Administration today approved Palynziq (pegvaliase-pqpz) for adults with arare and serious genetic disease known as phenylketonuria (PKU). Patients with PKU are born with an...

Ebola virus isolated in November 2014 from patient blood samples obtained in Mali. The virus was isolated on Vero cells.NIAID

Experimental Ebola treatment in Phase 1 clinical trial

By

A first-in-human trial evaluating an experimental treatment for Ebola virus disease has begun at the National Institutes of Health Clinical Center in Bethesda, Maryland. The Phase 1 clinical trial is...

Image/qimono

FDA issues warning to Utah company over unapproved Lyme disease product

By

Results RNA, LLC of Orem, UT was issued a warning letter from the Food and Drug Administration (FDA) last month over a number of unapproved/misbranded new drugs sold, including one for Lyme disease, where serious...

Image/CDC

CDC warns that gonorrhea monotherapy could accelerate antibiotic resistance

By

A recent CDC MMWR report shows that providers treated 81% of patients diagnosed with gonorrhea using CDC’s recommended dual therapy. While encouraging, nearly 1 in 5 patients were treated with a different...

Image/CDC

Vulvovaginal candidiasis treatment granted FDA QIDP and Fast Track designations

By

New Jersey based biotechnology company, SCYNEXIS, Inc. announced this week that the U.S. Food and Drug Administration(FDA) has granted both Qualified Infectious Disease Product (QIDP) and Fast Track...

Image/CDC/ John Noble, Jr., M.D.

Smallpox antiviral: FDA panel gives OK

By

SIGA Technologies, Inc. (SIGA), a health security company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, announced this week on a favorable...